首页 | 官方网站   微博 | 高级检索  
     

尿激酶型纤溶酶原激活物系统对骨巨细胞瘤细胞基质金属蛋白酶-2和组织基质金属蛋白酶抑制物-3表达的影响
引用本文:徐若冰,文剑明,张萌,吕长海,肖刚,张文敏,梁惠珍. 尿激酶型纤溶酶原激活物系统对骨巨细胞瘤细胞基质金属蛋白酶-2和组织基质金属蛋白酶抑制物-3表达的影响[J]. 中国病理生理杂志, 2004, 20(11): 1982-1988
作者姓名:徐若冰  文剑明  张萌  吕长海  肖刚  张文敏  梁惠珍
作者单位:1. 广州医学院病理学教研室, 广东 广州 510182;
2. 中山大学中山医学院病理学教研室, 广东 广州 510080;
3. 中山大学附属口腔医院儿童牙科, 广东 广州 510060
基金项目:教育部高等学校博士学科点专项科研基金资助项目 (No.2 0 0 0 4 6 )
摘    要:目的:研究尿激酶型纤溶酶原激活物(uPA)及其受体(uPAR)信号转导对骨巨细胞瘤基质金属蛋白酶-2(MMP-2)和金属蛋白酶组织抑制物-3(TIMP-3)的调节。方法:用免疫组化检测骨巨细胞瘤组织中uPAR、MMP-2和TIMP-3的表达。用免疫共沉淀法检测uPA对瘤细胞信号转导通路的p44蛋白磷酸化水平。用蛋白印迹法检测用uPA和uPAR抗体处理后瘤细胞MMP-2和TIMP-3蛋白表达。结果:(1)uPAR主要表达在部分单核基质细胞和一些多核巨细胞的胞膜上;(2)MMP-2主要表达在瘤细胞的胞浆,在多核巨细胞,其表达有明显的极向性;(3)在骨巨细胞瘤组织TIMP-3表达量低于MMP-2,在多核巨细胞也显示极向性表达;(4)将uPA-ATF加入培养的骨巨细胞瘤细胞后,细胞信号通路上的p44蛋白磷酸化水平明显增高。用uPAR抗体处理后,细胞p44蛋白磷酸化水平明显降低。说明uPA-ATF参与细胞信号转导,而且受uPAR拮抗剂的影响;(5)uPA-ATF信号通路上调MMP-2和TIMP-3的表达,而uPAR抗体则下调MMP-2和TIMP-3的表达。结论:本实验首次直接证明uPA-ATF通过信号转导能调节MMP-2和TIMP-3的表达,而后者则在骨巨细胞瘤局部骨质吸收中起重要作用。

关 键 词:巨细胞瘤    尿纤溶酶原激活物  信号转导  
文章编号:1000-4718(2004)11-1982-07
收稿时间:2004-04-20
修稿时间:2004-06-07

Regulation of MMP-2 and TIMP-3 expression by uPA signal transduction system in human bone giant cell tumor
XU Ruo-bing,WEN Jian-ming,ZHANG Meng,LV Chang-hai,XIAO Gang,ZHANG Wen-min,LIANG Hui-zhen. Regulation of MMP-2 and TIMP-3 expression by uPA signal transduction system in human bone giant cell tumor[J]. Chinese Journal of Pathophysiology, 2004, 20(11): 1982-1988
Authors:XU Ruo-bing  WEN Jian-ming  ZHANG Meng  LV Chang-hai  XIAO Gang  ZHANG Wen-min  LIANG Hui-zhen
Affiliation:1. Department of Pathology, Guangzhou Medical College, Guangzhou 510182, China;
2. Department of Pathology, Zhongshan Medical College of Sun Yat-sen University, Guangzhou 510080, China;
3. Affiliated stomatological Hospital, Sun Yat-sen University, Guangzhou 510060, China
Abstract:AIM: To study effects of urokinase-type plasminogen activator (uPA) signal transduction on expression of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) in giant cell tumor of bone (GCT). METHODS: Expression of uPAR, MMP-2 and TIMP-3 in GCT tissue was detected by immunohistochemistry. Phosphorylation level of mitogen-activated protein kinase (p44) in uPA/uPAR signal pathway in cultured GCT cells was detected by immunoprecipitation. The expression of MMP-2 and TIMP-3 in cultured cells after treatment with uPA-ATF or anti-uPAR antibody was also detected by Western blotting. RESULTS: 1) Urokinase-type plasminogen activator receptor (uPAR) was positive on the cell membrane and in cytoplasm of some mononuclear stromal cells (MSCs) and multinucleated giant cells (MGCs); 2) MMP-2 was positive in the cytoplasm and on the cell membrane of almost all of MSCs and some of MGCs. The polar distribution of MMP-2 in the cytoplasm of MGCs was especially obvious; 3) The expression of TIMP-3 of some MSCs and MGCs in GCT was much lower than MMP-2. The positive signal also showed a prominent polarity; 4) After treatment with uPA-ATF, the phosphorylation level of p44 in GCT cultured cells was much higher than the control. Addition of anti-uPAR antibody in the cells remarkably down-regulated the phosphorylation level of p44 as compared with the control group, suggesting that uPA-ATF participates cell signal transduction and this reaction can be inhibited by anti-uPAR antibody; 5) uPA-ATF cell signal pathway up-regulated expression of MMP-2 and TIMP-3, while anti-uPAR antibody down-regulated the expression of MMP-2 and TIMP-3. CONCLUSION: These results demonstrate for the first time that uPA-ATF directly regulates the expression of MMP-2 and TIMP-3 by signal transduction pathway, and the over-expression of MMP-2 and TIMP-3 may play an important role in local osteolysis of GCT. [
Keywords:Giant cell tumor   bone  Urinary plasminogen activator  Signal transduction
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号